Expected population impacts of discontinued prostate-specific antigen screening

BACKGROUND: Prostate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagnosis, particularly in older men, and reports from screening trials indicate that it saves few lives after 11–13 years of follow-up. New clinical guidelines recommend against PSA screening for all men...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer
Huvudupphovsmän: Gulati, Roman, Tsodikov, Alex, Etzioni, Ruth, Hunter-Merrill, Rachel A, Gore, John L, Mariotto, Angela B, Cooperberg, Matthew R
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221407/
https://ncbi.nlm.nih.gov/pubmed/25065910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28932
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk